US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CAR-T Concept

1,921.65

+10.230.54%

Number of Gainers:2

Number of Losers:- -

Number of Flat:- -

PE:- -

High:1,924.23

Open:1,916.26

Low:1,896.93

Close:1,911.04

Volume:3.77M

Turnover:592.14M

Market Cap:495.22B

Float Cap:479.87B

Loading ...

Gilead Sciences Initiated at Buy by Jefferies

Gilead : Jefferies Initiates Coverage With Buy Rating; Price Target $180

THOMSON REUTERS

Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading Day

Novartis price target raised to CHF 110 from CHF 92 at Berenberg

Novartis (NVS) Receives a Hold from Berenberg Bank

These 8 drugs could help fight dementia - and they're already on the market

Funds: What This Top International ETF Is Buying Now -- Barron's

Novartis Shareholders Approve Dividend Raise, Share Capital Reduction

MT Newswires Live

Novartis shareholders approve all resolutions proposed by Board of Directors

Gilead Sciences' HIV Drug Eyed for Local Production by South Africa

MT Newswires Live

Berenberg Raises Price Target on Novartis to $141 From $116, Keeps Hold Rating

MT Newswires Live

Gilead Sciences Inc. Stock Outperforms Competitors Despite Losses On The Day

Gilead Sciences to Buy Arcellx for $115 a Share Plus $5 CVR

Tango Therapeutics posts FY 2025 collaboration revenue of USD 62.4 million +108.2%

South Africa seeks local production of Gilead's HIV prevention drug

What This Top International ETF Is Buying Now -- Barrons.com

Gilead Sciences Inc. Stock Underperforms Tuesday When Compared To Competitors

Gilead Exec Says Anito-Cel Could Address an "up to $20 Billion" Multiple Myeloma Opportunity When Considering Use in First-Line Treatment- TD Cowen Conference

THOMSON REUTERS

Gilead Exec Says Anito-Cel Is Expected to Launch at the End of This Year - TD Cowen Conference

THOMSON REUTERS

Gilead Sciences CEO Daniel Patrick O'Day Disposes of Common Shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4578/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4578","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","market":"US","secType":"PLATE","nameCN":"CAR-T Concept","latestPrice":1921.263,"timestamp":1773163392536,"preClose":1911.0356,"halted":0,"volume":3770802,"delay":0,"changeRate":0.005352,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":10.227295,"latestTime":"03-10 13:23:12 EDT","open":1916.2566,"high":1924.2263,"low":1896.9325,"amount":592143948.394822,"amplitude":0.014282,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1773172800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":7.055125,"peRate":21.588793,"turnoverRate":0.001234,"increases":1,"decrements":0,"flats":1,"marketCap":495216459776,"floatMarketCap":479865290752},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","high":1924.2263,"amplitude":0.014282,"preClose":1911.0356,"low":1896.9325,"pbRate":"7.055125","latestPrice":1921.6516,"volume":3766009,"delay":0,"open":1916.2566,"prevYearClose":1612.5378,"prevWeekClose":1878.0505,"prevMonthClose":1965.2883,"prevQuarterClose":1612.5378,"fiveDayClose":1927.1906,"twentyDayClose":1892.9263,"sixtyDayClose":1556.4049,"secType":"PLATE","market":"US","turnoverRate":0.001233,"peRate":21.588793,"marketCap":495279423488,"floatMarketCap":479926370304,"timestamp":1773163387948,"nameCN":"CAR-T Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4578\",,,,undefined,":{"bkCode":"BK4578","up":2,"down":0,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4578\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2618495650","title":"Gilead Sciences Initiated at Buy by Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2618495650","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618495650?lang=en_us&edition=fundamental","pubTime":"2026-03-10 21:52","pubTimestamp":1773150720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GILD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 10, 2026 09:52 ET (13:52 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1023059063.AUD","LU1585245621.USD","LU2468319806.SGD","LU1066053197.SGD","IE00BZ1G4Q59.USD","LU0965509283.SGD","BK4568","IE00BSNM7G36.USD","LU0234570918.USD","SG9999015952.SGD","BK4585","LU0889565916.HKD","LU0965509010.AUD","LU1066051498.USD","LU1430594728.SGD","LU0965509101.SGD","IE00B19Z3581.USD","LU0965508806.USD","LU0823416689.USD","LU0861579265.USD","LU1934455277.USD","LU0058720904.USD","IE00B19Z3B42.SGD","BK4588","LU0882574055.USD","LU2324357040.USD","BK4139","BK4566","BK4578","LU0114720955.EUR","LU1778281490.HKD","LU0320765992.SGD","LU0109394709.USD","LU1839511570.USD","IE00B3T34201.USD","IE00B7SZLL34.SGD","LU2112291526.USD","BK4583","LU1571399168.USD","GILD","BK4550","LU1057294990.SGD","LU2089984988.USD","LU1934455863.HKD","SG9999015986.USD","SG9999015978.USD","LU1674673428.USD","LU2087621335.USD","LU1037948541.HKD","LU1037948897.HKD"],"gpt_icon":0},{"id":"2618936630","title":"Gilead : Jefferies Initiates Coverage With Buy Rating; Price Target $180","url":"https://stock-news.laohu8.com/highlight/detail?id=2618936630","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618936630?lang=en_us&edition=fundamental","pubTime":"2026-03-10 17:59","pubTimestamp":1773136742,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260310:nFWN3ZY0XK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1037948897.HKD","BK4566","SG9999015986.USD","LU1934455194.USD","BK4585","IE00BKVL7J92.USD","LU0109394709.USD","IE00B7SZLL34.SGD","LU0965508806.USD","LU0889565916.HKD","LU2087621335.USD","LU1430594728.SGD","LU2468319806.SGD","SG9999015978.USD","IE00BSNM7G36.USD","LU0861579265.USD","GILD","BK4532","LU1571399168.USD","LU0882574055.USD","IE00B19Z3581.USD","LU0320765992.SGD","BK4568","LU1023059063.AUD","LU2112291526.USD","LU1066053197.SGD","BK4583","LU1057294990.SGD","LU0965509283.SGD","LU0823416689.USD","IE00BZ1G4Q59.USD","LU0122379950.USD","LU0234570918.USD","BK4588","LU1066051498.USD","LU1061106388.HKD","SG9999015952.SGD","LU0965509010.AUD","LU1934455277.USD","LU1934455863.HKD","IE0002270589.USD","LU1037948541.HKD","LU1674673691.USD","LU1839511570.USD","BK4578","BK4550","LU1778281490.HKD","LU0058720904.USD","BK4139","IE00B19Z3B42.SGD"],"gpt_icon":0},{"id":"2618725806","title":"Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2618725806","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618725806?lang=en_us&edition=fundamental","pubTime":"2026-03-10 04:34","pubTimestamp":1773088440,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  advanced 1.88% to $146.63 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.83% to 6,795.99 and the Dow Jones Industrial Average  rising 0.50% to 47,740.80.The stock's rise snapped a two-day losing streak.Gilead Sciences Inc. closed 6.78% short of its 52-week high of $157.29, which the company achieved on February 11th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson  rose 0.91% to $242.59, Pfizer Inc.  fell 0.89% to $26.81, and Abbott Laboratories  rose 2.82% to $112.65.Trading volume  remained 2.0 million below its 50-day average volume of 7.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled March 9, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published inde","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF631.EUR","LU1037948541.HKD","LU1066051498.USD","LU1934455863.HKD","IE00B3T34201.USD","IE00BVYPNV92.GBP","LU1732800096.USD","LU2211815571.USD","LU0070217475.USD","LU0345769631.USD","LU0225771236.USD","LU2112291526.USD","SG9999002232.USD","LU2089984988.USD","LU0320765646.SGD","IE00BN8TJ469.HKD","LU1244550221.USD","LU1162221912.USD","LU0795875169.SGD","LU2471134796.USD","LU0965508806.USD","LU0985481810.HKD","BK4592","LU1894683348.USD","SG9999011175.SGD","LU2430703251.USD","LU0689626769.HKD","LU2129689605.HKD","LU0882574055.USD","LU0795875086.SGD","BK4504","BK4550","IE00BSNM7G36.USD","IE00BFTCPJ56.SGD","LU1989763690.USD","LU2129689431.USD","SG9999001176.USD","LU1261432733.SGD","LU1571399168.USD","BK4568","SG9999001440.SGD","LU2468319806.SGD","LU0345770308.USD","LU0683600562.USD","LU0114720955.EUR","LU1032466523.USD","LU1066051225.USD","IE00BFXG1179.USD","SG9999001176.SGD","LU0321505439.SGD","IE00B7SZLL34.SGD","LU0306806265.USD","LU1057294990.SGD","LU0456855351.SGD","LU0234572021.USD","LU2750360641.GBP","BK4559","SG9999015986.USD","LU0098860793.USD","LU1506573853.SGD","BK4599","LU2347655156.SGD","IE00B3PB1722.GBP","IE00BZ1G4Q59.USD","LU2133065610.SGD","IE0009355771.USD","LU1023059063.AUD","IE00B19Z3B42.SGD","LU2602419157.SGD","SG9999015952.SGD","LU1691799644.USD","SG9999015945.SGD","LU1280957306.USD","LU1883839398.USD","LU1074936037.SGD","LU0124676726.USD","LU0170899867.USD","LU0289739699.SGD","IE00B2B36J28.USD","LU0787776722.HKD","IE00BVYPNW00.USD","LU1914381329.SGD","LU0234570918.USD","BK4007","LU0225284248.USD","BK4534","LU1196500208.SGD","IE00BLSP4452.SGD","LU1929549753.HKD","LU0889565916.HKD","LU1244550494.USD","BK4581","LU0640476718.USD","LU2471134879.HKD","LU1066051811.HKD","IE00B1BXHZ80.USD","LU0868494617.USD","BK4585","LU0432979614.USD","LU0823416689.USD","LU0861579265.USD","LU0203347892.USD","IE00BDGV0183.EUR","LU1066053197.SGD","LU0912757837.SGD","LU0466842654.USD","SGXZ57979304.SGD","LU2505996509.AUD","LU2324357040.USD","LU1061106388.HKD","LU1894683264.USD","LU2750360997.AUD","IE00B19Z3581.USD","IE00B42XCP33.USD","LU2237957811.SGD","LU1934455277.USD","SG9999002224.SGD","LU1674673691.USD","LU1839511570.USD","BK4532","LU1778281490.HKD","LU0792757196.USD","LU1059921491.USD","LU2129689514.USD","SGXZ41872573.SGD","IE00BLSP4239.USD","BK4533","BK4588","IE0001KFT4U8.USD","GILD","LU1718418525.SGD","LU1244550577.SGD","IE00B4R5TH58.HKD","IE0034235303.USD","LU0889566641.SGD","LU0965509101.SGD","LU1585245621.USD","SG9999003800.SGD","SG9999015978.USD","LU0122379950.USD","IE0002270589.USD","LU0985320562.USD","LU0965509010.AUD","LU2592432038.USD","LU1430594728.SGD","SG9999013999.USD","LU1983299246.USD","LU0965509283.SGD","LU1989763427.SGD","SGXZ23171101.USD","LU1221951129.SGD","LU0203345920.USD","LU0321505868.SGD","LU1674673428.USD","LU1032955483.USD","LU1721429402.USD","LU1496350502.SGD","BK4578","LU0320765992.SGD","IE000M9KFDE8.USD","LU0058720904.USD","BK4139","LU1934455194.USD","LU1221951046.USD","IE00BJJMRZ35.SGD","LU1267930813.SGD","LU2471134952.CNY","SG9999004303.SGD","LU1037948897.HKD","LU2505996681.GBP","IE00BBT3K403.USD","LU0345770993.USD","LU2237957902.USD","LU2471134523.USD","LU2087621335.USD","BK4566","LU1935042991.SGD","IE0002141913.USD","IE00BJT1NW94.SGD","LU2430703178.SGD","BK4583","LU0266013472.USD","LU0306807586.USD","LU1732799900.SGD","LU1721429741.USD","LU2430703095.HKD","IE00BKVL7J92.USD","BK4082","LU0109394709.USD","LU0345769128.USD"],"gpt_icon":0},{"id":"2618794546","title":"Novartis price target raised to CHF 110 from CHF 92 at Berenberg","url":"https://stock-news.laohu8.com/highlight/detail?id=2618794546","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618794546?lang=en_us&edition=fundamental","pubTime":"2026-03-10 02:55","pubTimestamp":1773082556,"startTime":"0","endTime":"0","summary":"Berenberg analyst Kerry Holford raised the firm’s price target on Novartis (NVS) to CHF 110 from CHF 92 and keeps a Hold rating on the shares. Publ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novartis-price-target-raised-to-chf-110-from-chf-92-at-berenberg-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novartis-price-target-raised-to-chf-110-from-chf-92-at-berenberg-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BFTCPJ56.SGD","BK4578","IE00BJT1NW94.SGD","IE0002141913.USD","LU0320765489.SGD","BK4532","BK4007","BK4588","IE00B4R5TH58.HKD","NVS","LU0211331839.USD","BK4585","IE0009355771.USD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU0070302665.USD","LU0208291251.USD"],"gpt_icon":0},{"id":"2618617262","title":"Novartis (NVS) Receives a Hold from Berenberg Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2618617262","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618617262?lang=en_us&edition=fundamental","pubTime":"2026-03-09 14:36","pubTimestamp":1773038178,"startTime":"0","endTime":"0","summary":"In a report released on March 6, from Berenberg Bank maintained a Hold rating on Novartis, with a price target of $141.00. The company’s shares clo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/novartis-nvs-receives-a-hold-from-berenberg-bank-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/novartis-nvs-receives-a-hold-from-berenberg-bank-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009355771.USD","IE00BFTCPJ56.SGD","BK4532","IE00B2B36J28.USD","NVS","IE00B4R5TH58.HKD","LU0208291251.USD","LU0211331839.USD","LU0320765489.SGD","IE00BJJMRZ35.SGD","LU0070302665.USD","BK4007","BK4585","BK4578","IE00BJT1NW94.SGD","IE0002141913.USD","BK4588"],"gpt_icon":0},{"id":"2617650744","title":"These 8 drugs could help fight dementia - and they're already on the market","url":"https://stock-news.laohu8.com/highlight/detail?id=2617650744","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617650744?lang=en_us&edition=fundamental","pubTime":"2026-03-07 23:00","pubTimestamp":1772895600,"startTime":"0","endTime":"0","summary":"Getting yourself vaccinated against shingles doesn't just protect you against that painful and debilitating disease - it may also slash your risk of developing Alzheimer's by as much as 20%, according to a recent study involving hundreds of thousands of people.And that finding, based on the closest thing you can get to gold-standard methodology in the real world, is among the reasons that a worldwide group of scientists have placed the shingles vaccine at the head of a list of drugs already on the market that they want studied in more detail for their possible benefits in the war on dementia.Among them is the erectile-dysfunction pill Viagra . It was first tested in the 1980s as a treatment for angina, the heart disease, and it is currently used for treatment of pulmonary hypertension as well as ED. Researchers cited various medical mechanisms by which the drug could help prevent Alzheimer's or other dementias. Two large studies based on health-insurance databases found that those who ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1929549753.HKD","GSK.UK","LU2106854487.HKD","LU2089984988.USD","BK4559","LU0211331839.USD","LU1983299246.USD","BK4533","LU2468319806.SGD","BK4532","LU1116320737.USD","LU1066051225.USD","LU2023250843.SGD","LU1989772840.SGD","LU2361045086.USD","SG9999014542.SGD","BK4550","IE00B1BXHZ80.USD","LU1934455277.USD","IE00BLSP4452.SGD","LU2324357040.USD","MRK","LU1162221912.USD","LU0965509283.SGD","LU0234572021.USD","SG9999001176.SGD","LU0006306889.USD","LU2125154778.USD","LU0985320562.USD","LU0648001328.SGD","BK4578","LU1894683348.USD","LU2461242641.AUD","IE00B19Z3581.USD","LU0106261372.USD","LU1941712264.USD","LU1093756168.USD","LU0965509101.SGD","LU1066053197.SGD","LU1201861249.SGD","LU2361044865.SGD","SG9999015358.SGD","LU0130517989.USD","IE00BJJMRZ35.SGD","LU0122379950.USD","LU2112291526.USD","IE0009355771.USD","LU0321505439.SGD","LU0208291251.USD","LU0170899867.USD","LU1934455863.HKD","LU1917777945.USD","LU0861579265.USD","LU1989771016.USD","LU1894683264.USD","LU0098860793.USD","IE00B19Z3B42.SGD","LU1585245621.USD","LU1699723380.USD","LU0456855351.SGD","LU0058720904.USD","LU2023250504.SGD","LU0320765646.SGD","GSKH","LU0980610538.SGD","LU1061106388.HKD","LU1093756325.SGD","SG9999015341.SGD","SG9999014559.SGD","LU1037948541.HKD","LU2361044949.HKD","LU0266013472.USD","LU1974910355.USD","LU1829250122.USD","PFE","LU0238689110.USD","LU0942090050.USD","SG9999013999.USD","LU0432979614.USD","LU0289739699.SGD","TAK","LU1057294990.SGD","IE00BSNM7G36.USD","LU0130102774.USD","IE0002270589.USD","BK4534","LU0868494708.USD","IE00BJT1NW94.SGD","LU1069347547.HKD","SG9999014567.USD","SG9999003800.SGD","LU1989772923.USD","LU0203347892.USD","NVS","BK4516","LU0965509010.AUD","LU0070302665.USD","LU0985481810.HKD","LU0306806265.USD","LU1037948897.HKD","BK4588","LU1883839398.USD","BK4581","LU0225771236.USD","LU0265550359.USD","IE00BBT3K403.USD","SG9999002224.SGD","SG9999011175.SGD","LU1571399168.USD","LU0477156953.USD","LU1291159041.SGD","BK4585","BK4007","LU1035773651.USD","IE00B2B36J28.USD","LU1430594728.SGD","LU2125154935.USD","IE00BFTCPJ56.SGD","SG9999001176.USD","LU0320765489.SGD","IE0002141913.USD","IE00BN8TJ469.HKD","LU0965508806.USD","BK4599","LU0203345920.USD","IE000M9KFDE8.USD","LU1116320901.HKD","LU1066051498.USD","LU1934455194.USD","SG9999001440.SGD","LU1941712348.USD","LU2360032135.SGD","SG9999014575.USD","IE00BLSP4239.USD","LU1023059063.AUD","LU1066051811.HKD","BK4592","LU0265550946.USD","IE00B4R5TH58.HKD","LU0225284248.USD","SG9999002232.USD","SGXZ57979304.SGD","BK4568","LU0868494617.USD","GSK","LU0321505868.SGD","LU0306807586.USD"],"gpt_icon":0},{"id":"2617651396","title":"Funds: What This Top International ETF Is Buying Now -- Barron's","url":"https://stock-news.laohu8.com/highlight/detail?id=2617651396","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617651396?lang=en_us&edition=fundamental","pubTime":"2026-03-07 10:30","pubTimestamp":1772850600,"startTime":"0","endTime":"0","summary":"If you're bargain hunting for international stocks after the Iran war slide, you'd be hard-pressed to find a better choice than the Lazard International Dynamic Equity exchange-traded fund. You'll get all of the country and sector exposure of foreign index funds, but with better stocks.The $878 million ETF has an 11.1% 10-year annualized return, beating 91% of its peers in Morningstar's foreign large blend fund category as well as the behemoth $606 billion Vanguard Total International Stock ETF's 10.6% return during the same period.Instead of favoring any particular signal, \"the goal is to have a balanced exposure to all of those all of the time,\" he says. \"That is really important, because what we're not trying to do is figure out when value is going to work versus when growth is going to work.\". But beneath the surface, on the individual stock level,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1734074674.USD","LU0208291251.USD","BK4543","LU0149721374.USD","LU0348735423.USD","BK1231","BK1572","LU0516422440.USD","LU0823434583.USD","BK1610","03165","BK4007","LU0345774631.USD","LU2063271972.USD","BK4532","HSBH","LU0516422366.SGD","LU0417516738.SGD","LU0540923850.HKD","BK4578","LU2236285917.USD","LU0516422952.EUR","LU0164880469.USD","IE00B4R5TH58.HKD","LU0823434740.USD","LU0052756011.USD","ASMU","HSHD.SI","LU0320765489.SGD","BK4521","IE00BJJMRZ35.SGD","LU0516423174.USD","LU0097036916.USD","IEQ","IE00B2B36J28.USD","LU0345774391.USD","LU0634319403.HKD","IE0004445239.USD","IE00BD6J9T35.USD","LU0070302665.USD","BK4585","IE0009355771.USD","LU0211331839.USD","LU0310800965.SGD","ASMG","BK4550","LU0516423091.SGD","LU2449936058.SGD","IE0002141913.USD","IE0008369823.USD","03143","LU1267930227.SGD","LU1481107354.HKD","BK4147","HSBA.UK","BK4207","BK4588","LU0128525689.USD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","BK1601"],"gpt_icon":0},{"id":"2617777636","title":"Novartis Shareholders Approve Dividend Raise, Share Capital Reduction","url":"https://stock-news.laohu8.com/highlight/detail?id=2617777636","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617777636?lang=en_us&edition=fundamental","pubTime":"2026-03-06 23:07","pubTimestamp":1772809658,"startTime":"0","endTime":"0","summary":"Novartis  said Friday its shareholders have approved a dividend increase of 5.7% to 3.70 Swiss francs  per share for 2025.The dividend will be paid from March 12, Novartis said.Shareholders have also approved a proposal by the board to cancel about 77.6 million shares and to decrease the share capital accordingly by about 38 million Swiss francs to roughly 997.1 million Swiss francs, the company said.Shareholders also confirmed Giovanni Caforio as board chair, as well as the other members of the board who stood for re-election, the company said. Charles Swanton was newly elected as member of the board, Novartis said, adding Daniel Hochstrasser did not stand for re-election.Price: 158.30, Change: -2.71, Percent Change: -1.68","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4578","BK4532","IE00BJT1NW94.SGD","BK4588","BK4007","LU0208291251.USD","IE00BJJMRZ35.SGD","LU0070302665.USD","IE0002141913.USD","NVS","LU0320765489.SGD","IE00B2B36J28.USD","BK4585","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU0211331839.USD","IE0009355771.USD"],"gpt_icon":0},{"id":"2617063689","title":"Novartis shareholders approve all resolutions proposed by Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2617063689","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617063689?lang=en_us&edition=fundamental","pubTime":"2026-03-06 22:31","pubTimestamp":1772807484,"startTime":"0","endTime":"0","summary":"Novartis (NVS) shareholders agreed to the Board of Directors’ recommendations for all proposed resolutions at the company’s Annual General Meeting....","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novartis-shareholders-approve-all-resolutions-proposed-by-board-of-directors-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novartis-shareholders-approve-all-resolutions-proposed-by-board-of-directors-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009355771.USD","IE00B2B36J28.USD","BK4585","IE0002141913.USD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU0208291251.USD","BK4007","LU0070302665.USD","LU0320765489.SGD","IE00B4R5TH58.HKD","BK4532","IE00BJJMRZ35.SGD","LU0211331839.USD","BK4578","NVS","BK4588"],"gpt_icon":0},{"id":"2617680747","title":"Gilead Sciences' HIV Drug Eyed for Local Production by South Africa","url":"https://stock-news.laohu8.com/highlight/detail?id=2617680747","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617680747?lang=en_us&edition=fundamental","pubTime":"2026-03-06 21:05","pubTimestamp":1772802320,"startTime":"0","endTime":"0","summary":"Gilead Sciences  is working with the South African government to come to an agreement that would enable the local production of HIV prevention drug lenacapavir, World Health Organization partner Unitaid said Friday.The government is working with global health organizations, including Unitaid and United States Pharmacopeia, to identify a South African pharmaceutical manufacturer that can produce the drug with quality assurance, Unitaid said.A finalized agreement would allow the manufacturer to become the seventh firm licensed to produce lenacapavir for low- and middle-income countries, joining six other firms in Egypt, India, and Pakistan, Unitaid said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0965508806.USD","BK4585","LU2324357040.USD","BK4532","BK4568","BK4583","IE0002270589.USD","IE00BKVL7J92.USD","LU1066051498.USD","LU2087621335.USD","LU1037948541.HKD","LU0882574055.USD","LU1023059063.AUD","BK4578","LU0823416689.USD","SG9999015945.SGD","LU1674673691.USD","LU2468319806.SGD","LU1585245621.USD","IE00B7SZLL34.SGD","LU0058720904.USD","LU1571399168.USD","IE00B3T34201.USD","LU1934455194.USD","LU1778281490.HKD","LU0861579265.USD","LU1066053197.SGD","LU1934455863.HKD","LU1839511570.USD","LU1430594728.SGD","LU0114720955.EUR","LU0122379950.USD","BK4139","IE00BZ1G4Q59.USD","LU1934455277.USD","LU0109394709.USD","LU2112291526.USD","LU2089984988.USD","BK4566","SG9999015952.SGD","IE00B19Z3B42.SGD","LU0965509283.SGD","BK4588","GILD","LU0889565916.HKD","BK4550","SG9999015986.USD","IE00B19Z3581.USD","LU0965509010.AUD","LU1061106388.HKD"],"gpt_icon":0},{"id":"2617682845","title":"Berenberg Raises Price Target on Novartis to $141 From $116, Keeps Hold Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2617682845","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617682845?lang=en_us&edition=fundamental","pubTime":"2026-03-06 19:30","pubTimestamp":1772796645,"startTime":"0","endTime":"0","summary":"Novartis (NVS) has an average rating of hold and mean price target of $153.08, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4532","BK4007","IE00B4R5TH58.HKD","NVS","LU0320765489.SGD","LU0208291251.USD","IE00BJT1NW94.SGD","IE0002141913.USD","IE00B2B36J28.USD","BK4578","IE00BJJMRZ35.SGD","LU0211331839.USD","BK4588","IE0009355771.USD","LU0070302665.USD","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"2617928579","title":"Gilead Sciences Inc. Stock Outperforms Competitors Despite Losses On The Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2617928579","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617928579?lang=en_us&edition=fundamental","pubTime":"2026-03-06 05:35","pubTimestamp":1772746500,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  slid 2.08% to $145.14 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.56% to 6,830.71 and Dow Jones Industrial Average  falling 1.61% to 47,954.74.Gilead Sciences Inc. closed 7.72% below its 52-week high of $157.29, which the company achieved on February 11th.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson  fell 2.31% to $239.63, Pfizer Inc.  fell 0.04% to $26.61, and Abbott Laboratories  fell 1.82% to $111.04.Trading volume  remained 610,527 below its 50-day average volume of 7.5 M.Data source: Dow Jones Market Data, FactSet. Data compiled March 5, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0124676726.USD","LU0868494617.USD","LU0432979614.USD","IE000M9KFDE8.USD","LU2750360641.GBP","BK4566","LU1196500208.SGD","SG9999003800.SGD","IE00BJJMRZ35.SGD","IE0001KFT4U8.USD","IE00B42XCP33.USD","LU1221951129.SGD","BK4599","LU2089984988.USD","LU0170899867.USD","LU2324357040.USD","SG9999001440.SGD","BK4583","LU0640476718.USD","BK4568","LU0234572021.USD","LU0321505439.SGD","LU1718418525.SGD","IE00BGHQF631.EUR","IE00B7SZLL34.SGD","SG9999011175.SGD","LU0203345920.USD","IE00BDGV0183.EUR","LU1032955483.USD","IE00BBT3K403.USD","LU0345769631.USD","LU0345770308.USD","LU0985320562.USD","LU2471134523.USD","LU1496350502.SGD","LU0058720904.USD","IE00BLSP4452.SGD","LU2468319806.SGD","BK4082","LU1674673428.USD","SG9999001176.SGD","LU1261432733.SGD","LU0689626769.HKD","LU1244550577.SGD","LU0122379950.USD","LU2471134879.HKD","SG9999002232.USD","LU0225771236.USD","IE00BZ1G4Q59.USD","LU1162221912.USD","LU1839511570.USD","IE00B3T34201.USD","LU1057294990.SGD","LU1059921491.USD","LU2211815571.USD","LU2471134796.USD","IE0034235303.USD","SG9999004303.SGD","SG9999015986.USD","LU1221951046.USD","LU2112291526.USD","LU0466842654.USD","LU1894683264.USD","LU2602419157.SGD","LU0225284248.USD","LU2430703095.HKD","LU1571399168.USD","LU1934455277.USD","IE00BSNM7G36.USD","IE00B1BXHZ80.USD","LU2129689431.USD","LU2347655156.SGD","IE00BN8TJ469.HKD","LU0306806265.USD","LU1430594728.SGD","LU0321505868.SGD","LU1989763427.SGD","LU2471134952.CNY","LU1244550494.USD","IE00B19Z3B42.SGD","LU0912757837.SGD","BK4534","LU0965509101.SGD","SGXZ23171101.USD","LU2087621335.USD","BK4532","LU2237957811.SGD","BK4550","SG9999013999.USD","LU0965509010.AUD","SG9999015945.SGD","LU0683600562.USD","BK4578","LU1506573853.SGD","BK4592","BK4559","LU1244550221.USD","SG9999015952.SGD","LU1267930813.SGD","LU0203347892.USD","LU0289739699.SGD","LU2129689514.USD","LU1066053197.SGD","IE00B19Z3581.USD","LU0882574055.USD","LU0795875169.SGD","IE00BVYPNW00.USD","LU0320765992.SGD","LU1066051498.USD","LU1066051811.HKD","LU0965508806.USD","GILD","BK4504","IE00BJT1NW94.SGD","LU1032466523.USD","BK4007","SGXZ41872573.SGD","LU2592432038.USD","IE00BLSP4239.USD","LU0109394709.USD","LU1074936037.SGD","BK4139","LU2237957902.USD","SG9999002224.SGD","LU2129689605.HKD","IE00BVYPNV92.GBP","LU1280957306.USD","BK4585","IE00B4R5TH58.HKD","LU1023059063.AUD","LU2430703251.USD","LU1037948541.HKD","LU0889565916.HKD","LU1894683348.USD","LU1778281490.HKD","SG9999001176.USD","LU1934455194.USD","IE0002270589.USD","LU2505996509.AUD","IE00B2B36J28.USD","LU0456855351.SGD","LU0985481810.HKD","LU1066051225.USD","LU1883839398.USD","LU1061106388.HKD","LU1914381329.SGD","LU1732799900.SGD","LU2133065610.SGD","LU0345770993.USD","SG9999015978.USD","IE00B3PB1722.GBP","IE00BKVL7J92.USD","LU0861579265.USD","LU1934455863.HKD","SGXZ57979304.SGD","LU2750360997.AUD","BK4588","LU2430703178.SGD","BK4533","LU0234570918.USD","LU0965509283.SGD","IE00BFTCPJ56.SGD","LU1983299246.USD","IE00BFXG1179.USD","LU1037948897.HKD","LU1935042991.SGD","LU1721429402.USD","LU1691799644.USD","LU0098860793.USD","LU0266013472.USD","LU2505996681.GBP","LU0823416689.USD","LU0795875086.SGD","LU0889566641.SGD","LU0320765646.SGD","LU0345769128.USD","LU0792757196.USD","LU0070217475.USD","LU1989763690.USD","LU0114720955.EUR","LU0787776722.HKD","IE0009355771.USD","LU0306807586.USD","LU1732800096.USD","LU1674673691.USD","LU1721429741.USD","BK4581","LU1929549753.HKD","IE0002141913.USD","LU1585245621.USD"],"gpt_icon":0},{"id":"2617520162","title":"Gilead Sciences to Buy Arcellx for $115 a Share Plus $5 CVR","url":"https://stock-news.laohu8.com/highlight/detail?id=2617520162","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617520162?lang=en_us&edition=fundamental","pubTime":"2026-03-06 02:36","pubTimestamp":1772735801,"startTime":"0","endTime":"0","summary":"Arcellx is being acquired by Gilead Sciences for $115.00 per share in cash plus a contingent value right worth up to an additional $5.00 per share if certain milestones are achieved, according to Halper Sadeh LLC.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nNDL6v0KlW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","ACLX","BK4550","LU0314104364.USD","LU0289739699.SGD","LU1023059063.AUD","LU1585245621.USD","LU1778281490.HKD","BK4566","LU1934455277.USD","LU1571399168.USD","LU2468319806.SGD","LU1037948897.HKD","LU1934455194.USD","IE00B19Z3B42.SGD","IE0002270589.USD","LU0122379950.USD","LU1061106388.HKD","LU2210149790.SGD","LU1430594728.SGD","LU0965509101.SGD","SG9999015952.SGD","BK4139","LU1674673691.USD","LU0861579265.USD","LU0058720904.USD","LU0234570918.USD","IE00BZ1G4Q59.USD","SG9999014013.SGD","IE00B7SZLL34.SGD","SG9999015978.USD","LU1934455863.HKD","LU2324357040.USD","LU0882574055.USD","GILD","LU2087621335.USD","LU2210150020.SGD","SG9999014005.SGD","LU0889565916.HKD","BK4578","LU1057294990.SGD","LU1037948541.HKD","LU2089984988.USD","BK4568","BK4112","LU0965509283.SGD","LU2095319765.USD","IE00BSNM7G36.USD","IE00B19Z3581.USD","NDAQ"],"gpt_icon":0},{"id":"2617541232","title":"Tango Therapeutics posts FY 2025 collaboration revenue of USD 62.4 million +108.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617541232","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617541232?lang=en_us&edition=fundamental","pubTime":"2026-03-05 20:01","pubTimestamp":1772712112,"startTime":"0","endTime":"0","summary":"Tango Therapeutics posts FY 2025 collaboration revenue of USD 62.4 million +108.2%               Tango Therapeutics posted a Q4 2025 net loss of USD 38.7 million, or USD 0.29 per share, and a FY 2025 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nNDLb8fTRl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","IE00BKVL7J92.USD","LU0861579265.USD","LU2210149790.SGD","RVMD","BK4139","BK4578","LU0965509101.SGD","LU1430594728.SGD","LU1934455277.USD","IE0002270589.USD","TNGX","SG9999014021.USD","GILD","BK4585","LU0823416689.USD","LU0889565916.HKD","LU2089984988.USD","LU2468319806.SGD","LU2112291526.USD","BK4568","LU1674673428.USD","LU0114720955.EUR","IE00BGHQF748.EUR","NDAQ","IE00B3T34201.USD","LU0289739699.SGD","LU1585245621.USD","ERAS","IE00B19Z3581.USD","IE00BZ1G4Q59.USD","BK4532","SG9999014013.SGD","LU2324357040.USD","LU1037948541.HKD","SG9999015978.USD","SG9999015952.SGD","LU1778281490.HKD","BK4539","LU0965509283.SGD","LU1061106388.HKD","IE00B7SZLL34.SGD","LU2087621335.USD","LU0965508806.USD","BK4566","BK4550","LU1066051498.USD","IE00B19Z3B42.SGD","LU1023059063.AUD","LU1674673691.USD"],"gpt_icon":0},{"id":"2617813518","title":"South Africa seeks local production of Gilead's HIV prevention drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2617813518","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617813518?lang=en_us&edition=fundamental","pubTime":"2026-03-05 14:00","pubTimestamp":1772690400,"startTime":"0","endTime":"0","summary":"South Africa seeks local production of Gilead's HIV prevention drugSouth Africa aims to boost access to HIV prevention drug nationally and regionallyLenacapavir could help bring an end to 44-year old ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260305:nL6N3ZS19K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","SG9999015986.USD","LU2324357040.USD","LU1674673691.USD","IE00B7SZLL34.SGD","IE0002270589.USD","LU0109394709.USD","IE00B19Z3B42.SGD","BK4588","BK4568","BK4139","LU1839511570.USD","IE00BZ1G4Q59.USD","IE00B3T34201.USD","LU0289739699.SGD","LU1037948541.HKD","LU1037948897.HKD","LU2112291526.USD","LU1571399168.USD","LU1066053197.SGD","LU1066051498.USD","IE00BKVL7J92.USD","LU0965509283.SGD","LU0965509101.SGD","LU0965508806.USD","LU1430594728.SGD","LU1057294990.SGD","GILD","LU0882574055.USD","LU1023059063.AUD","IE00B19Z3581.USD","SG9999015945.SGD","SG9999015952.SGD","LU1585245621.USD","LU2087621335.USD","BK4578","LU0058720904.USD","LU0320765992.SGD","LU0823416689.USD","LU0861579265.USD","IE00BSNM7G36.USD","LU0965509010.AUD","LU0122379950.USD","LU1778281490.HKD","BK4585","LU0889565916.HKD","LU2089984988.USD","LU0234570918.USD","LU1674673428.USD","BK4566"],"gpt_icon":0},{"id":"2616581572","title":"What This Top International ETF Is Buying Now -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2616581572","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616581572?lang=en_us&edition=fundamental","pubTime":"2026-03-04 15:00","pubTimestamp":1772607600,"startTime":"0","endTime":"0","summary":"If you're bargain hunting for international stocks after the Iran war slide, you'd be hard-pressed to find a better choice than the Lazard International Dynamic Equity exchange-traded fund. You'll get all of the country and sector exposure of foreign index funds, but with better stocks.By comparison, most mutual funds that convert to exchange-traded funds do so because they're struggling to compete with index ETFs. But Lazard's co-manager Paul Moghtader attributes this ETF's success to its balanced approach, as opposed to focusing on a single investment style. His quantitative team \"has a philosophy of building strategies that are designed to perform in different types of market environments,\" he says. \"We've researched a number of different signals to identify companies. Those signals broadly fall into the categories of value, growth, quality, and sentiment.\". The ETF wins by selecting the best stocks in the index's sectors and countries instead of making tactical sector and country o","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03165","BK1572","LU0417516738.SGD","HSBH","BK1610","BK4147","LU1734074674.USD","IE00BJJMRZ35.SGD","LU0070302665.USD","LU0052756011.USD","LU1267930227.SGD","LU0097036916.USD","IEQ","03143","BK4207","LU0345774631.USD","LU0516422366.SGD","LU1481107354.HKD","LU2236285917.USD","IE0008369823.USD","LU2063271972.USD","IE0002141913.USD","LU0211331839.USD","IE00BD6J9T35.USD","IE0004445239.USD","LU0823434740.USD","BK4550","BK4521","BK4007","HSHD.SI","LU0516423174.USD","IE0009355771.USD","ASMG","IE00B2B36J28.USD","LU0310800965.SGD","ASMU","IE00BFTCPJ56.SGD","BK4578","LU0320765489.SGD","LU2449936058.SGD","LU0516423091.SGD","LU0149721374.USD","BK1231","BK1601","BK4532","LU0345774391.USD","LU0823434583.USD","LU0634319403.HKD","HSBA.UK","BK4543","IE00B4R5TH58.HKD","LU0540923850.HKD","BK4585","LU0348735423.USD","LU0208291251.USD","LU0516422440.USD","LU0516422952.EUR","LU0128525689.USD","IE00BJT1NW94.SGD","LU0164880469.USD","BK4588"],"gpt_icon":0},{"id":"2616374765","title":"Gilead Sciences Inc. Stock Underperforms Tuesday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2616374765","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616374765?lang=en_us&edition=fundamental","pubTime":"2026-03-04 05:35","pubTimestamp":1772573700,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  slipped 1.47% to $147.83 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.94% to 6,816.63 and Dow Jones Industrial Average  falling 0.83% to 48,501.27.The stock's fall snapped a two-day winning streak.Gilead Sciences Inc. closed 6.01% below its 52-week high of $157.29, which the company achieved on February 11th.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson  fell 0.73% to $246.75, Pfizer Inc.  fell 2.49% to $26.58, and Abbott Laboratories  fell 0.45% to $113.61.Trading volume  remained 1.2 million below its 50-day average volume of 7.5 M.Data source: Dow Jones Market Data, FactSet. Data compiled March 3, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independent","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","LU0320765646.SGD","IE00BLSP4452.SGD","LU0795875086.SGD","LU0203347892.USD","LU0787776722.HKD","LU2750360641.GBP","SG9999003800.SGD","LU0070217475.USD","LU0098860793.USD","IE0002141913.USD","LU1221951046.USD","IE0009355771.USD","LU1066053197.SGD","SG9999015945.SGD","LU0965509101.SGD","LU0985481810.HKD","LU2471134952.CNY","BK4588","IE0002270589.USD","LU0320765992.SGD","LU1066051498.USD","LU1037948541.HKD","LU2430703178.SGD","IE00BBT3K403.USD","IE00BFXG1179.USD","LU1778281490.HKD","LU2471134879.HKD","IE00BFTCPJ56.SGD","LU0306807586.USD","LU0912757837.SGD","LU1732800096.USD","LU0466842654.USD","BK4585","LU1221951129.SGD","SG9999015978.USD","LU0203345920.USD","BK4532","LU0345769128.USD","LU1718418525.SGD","LU1935042991.SGD","LU2324357040.USD","LU0861579265.USD","LU2592432038.USD","LU1057294990.SGD","LU1691799644.USD","LU1894683348.USD","LU1883839398.USD","BK4559","IE00BGHQF631.EUR","LU0889566641.SGD","LU0432979614.USD","LU0792757196.USD","BK4568","LU1162221912.USD","LU1721429402.USD","LU2750360997.AUD","IE00BKVL7J92.USD","BK4504","IE00B3T34201.USD","SGXZ57979304.SGD","LU1571399168.USD","LU1267930813.SGD","LU2129689605.HKD","LU1989763427.SGD","BK4583","LU0058720904.USD","LU0795875169.SGD","LU0225771236.USD","LU2468319806.SGD","GILD","LU0683600562.USD","LU2237957811.SGD","LU1983299246.USD","LU0321505868.SGD","LU2347655156.SGD","LU0689626769.HKD","LU2505996509.AUD","LU1032466523.USD","IE00BJJMRZ35.SGD","IE00B1BXHZ80.USD","IE00BVYPNW00.USD","IE00B4R5TH58.HKD","SG9999002232.USD","LU1929549753.HKD","IE00B3PB1722.GBP","LU0109394709.USD","LU1506573853.SGD","LU2505996681.GBP","SG9999013999.USD","BK4581","BK4578","LU1244550494.USD","LU0289739699.SGD","IE000M9KFDE8.USD","IE00B2B36J28.USD","BK4082","SGXZ23171101.USD","LU1023059063.AUD","BK4592","LU2133065610.SGD","LU2211815571.USD","LU2602419157.SGD","LU1066051225.USD","BK4534","LU0965509010.AUD","BK4007","LU0321505439.SGD","LU1674673691.USD","LU1430594728.SGD","LU0170899867.USD","LU0965508806.USD","SG9999001440.SGD","IE00B7SZLL34.SGD","BK4550","LU1496350502.SGD","IE00BJT1NW94.SGD","LU1261432733.SGD","LU0345770308.USD","LU1061106388.HKD","LU0345769631.USD","LU1839511570.USD","LU0122379950.USD","LU1066051811.HKD","LU2087621335.USD","LU2471134523.USD","LU0965509283.SGD","IE00B19Z3B42.SGD","LU0823416689.USD","LU1914381329.SGD","LU0985320562.USD","LU1032955483.USD","IE00BDGV0183.EUR","BK4566","LU2471134796.USD","IE0001KFT4U8.USD","LU2430703095.HKD","LU0456855351.SGD","BK4533","LU1037948897.HKD","IE00B42XCP33.USD","IE00BZ1G4Q59.USD","LU1244550577.SGD","LU1894683264.USD","LU0234570918.USD","LU0882574055.USD","SG9999001176.SGD","BK4139","LU0114720955.EUR","LU1674673428.USD","SG9999011175.SGD","LU2112291526.USD","LU0889565916.HKD","LU1059921491.USD","LU2129689431.USD","SG9999015952.SGD","IE00BVYPNV92.GBP","LU1074936037.SGD","IE00BSNM7G36.USD","LU0640476718.USD","IE0034235303.USD","LU1721429741.USD","SG9999002224.SGD","SG9999015986.USD","LU0225284248.USD","LU1196500208.SGD","LU1280957306.USD","LU2430703251.USD","LU0306806265.USD","LU1244550221.USD","LU2237957902.USD","SG9999001176.USD","SG9999004303.SGD","LU0345770993.USD","LU0266013472.USD","LU2089984988.USD","IE00BLSP4239.USD","LU1585245621.USD","SGXZ41872573.SGD","LU0234572021.USD","LU0124676726.USD","LU1732799900.SGD","LU2129689514.USD","BK4599","LU0868494617.USD","LU1989763690.USD","IE00BN8TJ469.HKD"],"gpt_icon":0},{"id":"2616322756","title":"Gilead Exec Says Anito-Cel Could Address an \"up to $20 Billion\" Multiple Myeloma Opportunity When Considering Use in First-Line Treatment- TD Cowen Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2616322756","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616322756?lang=en_us&edition=fundamental","pubTime":"2026-03-04 00:39","pubTimestamp":1772555945,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nFWN3ZR0QU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2112291526.USD","GILD","LU1585245621.USD","LU0109394709.USD","LU0122379950.USD","IE0002270589.USD","SG9999015986.USD","BK4566","LU1430594728.SGD","LU1674673691.USD","SG9999015952.SGD","BK4532","LU1778281490.HKD","LU1057294990.SGD","BK4583","LU2468319806.SGD","LU1571399168.USD","LU2324357040.USD","LU0882574055.USD","LU0965509283.SGD","LU0320765992.SGD","LU0861579265.USD","BK4568","LU0965508806.USD","LU1839511570.USD","LU2087621335.USD","LU0289739699.SGD","LU0114720955.EUR","LU0234570918.USD","BK4578","LU1037948541.HKD","SG9999015945.SGD","BK4585","LU2089984988.USD","LU0965509101.SGD","LU0889565916.HKD","IE00B19Z3581.USD","LU0823416689.USD","LU0058720904.USD","BK4139","IE00B7SZLL34.SGD","LU1023059063.AUD","LU1061106388.HKD","IE00BKVL7J92.USD","BK4588","BK4550","LU1674673428.USD","IE00BSNM7G36.USD","SG9999015978.USD","LU1037948897.HKD"],"gpt_icon":0},{"id":"2616071322","title":"Gilead Exec Says Anito-Cel Is Expected to Launch at the End of This Year - TD Cowen Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2616071322","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616071322?lang=en_us&edition=fundamental","pubTime":"2026-03-04 00:39","pubTimestamp":1772555945,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nFWN3ZR0QU:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0289739699.SGD","LU1061106388.HKD","LU1066053197.SGD","IE00B19Z3581.USD","SG9999015986.USD","LU0882574055.USD","BK4566","SG9999015978.USD","LU2112291526.USD","IE00BKVL7J92.USD","LU0861579265.USD","LU0320765992.SGD","LU1066051498.USD","LU2089984988.USD","BK4588","LU2324357040.USD","BK4583","LU0965509283.SGD","LU1571399168.USD","BK4568","GILD","LU0109394709.USD","LU1430594728.SGD","BK4139","LU0823416689.USD","IE00B19Z3B42.SGD","BK4585","LU1023059063.AUD","LU2468319806.SGD","LU0965509101.SGD","LU1037948541.HKD","LU0889565916.HKD","LU1674673428.USD","LU2087621335.USD","BK4532","BK4550","LU0122379950.USD","LU1778281490.HKD","LU0114720955.EUR","LU0965509010.AUD","IE00BZ1G4Q59.USD","LU1674673691.USD","SG9999015945.SGD","LU1839511570.USD","BK4578","IE0002270589.USD","IE00B3T34201.USD","LU1057294990.SGD","SG9999015952.SGD","LU1585245621.USD"],"gpt_icon":0},{"id":"2616361908","title":"Gilead Sciences CEO Daniel Patrick O'Day Disposes of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2616361908","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616361908?lang=en_us&edition=fundamental","pubTime":"2026-03-03 05:46","pubTimestamp":1772488016,"startTime":"0","endTime":"0","summary":"Daniel Patrick O'Day, Chairman and CEO of Gilead Sciences Inc., reported a disposal of the company’s common shares. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gilead Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 02, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nNDL2Z3m3L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gilead Sciences CEO Daniel Patrick O'Day Disposes of Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015986.USD","IE00B19Z3581.USD","LU2324357040.USD","IE00B7SZLL34.SGD","LU0122379950.USD","LU2087621335.USD","LU1037948541.HKD","LU0861579265.USD","LU0882574055.USD","LU1066051498.USD","LU2468319806.SGD","LU0114720955.EUR","LU0965509010.AUD","LU1061106388.HKD","BK4568","BK4139","BK4588","IE00B19Z3B42.SGD","IE00BZ1G4Q59.USD","LU1778281490.HKD","BK4550","BK4566","BK4585","GILD","LU0058720904.USD","LU0109394709.USD","LU1066053197.SGD","SG9999015945.SGD","LU1674673691.USD","LU1023059063.AUD","SG9999015978.USD","LU1037948897.HKD","LU0234570918.USD","LU0965509101.SGD","LU1430594728.SGD","LU1585245621.USD","LU1674673428.USD","LU1839511570.USD","IE00BSNM7G36.USD","BK4578","IE00BKVL7J92.USD","LU0320765992.SGD","IE00B3T34201.USD","LU2112291526.USD","LU0289739699.SGD","BK4583","LU1057294990.SGD","LU0965508806.USD","LU2089984988.USD","IE0002270589.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":49,"code":"91000000","status":"200"}]}}